In een gesprek met Vogue deelt Serena Williams dat ze afslankmedicijn GLP-1 gebruikt. "Transparantie is voor mij belangrijk." ...

Serena Williams is opening up about her fitness journey, revealing that she uses the injectable GLP-1 weight loss drug ...

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...

Fabrikanten van afslankmedicijnen wordt verwacht meer dan 150 miljard dollar aan omzet binnen te halen in het begin van de ...

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...

Serena Williams has a new doubles partner. The 23-time Grand Slam tennis champion is working with Ro, speaking out about how ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Fabrikanten van afslankmedicijnen zullen naar verwachting tegen begin 2030 meer dan $150 miljard aan inkomsten binnenhalen, dankzij de toenemende populariteit van Eli Lilly’s Zepbound en Novo Nordisk’ ...

Serena Williams revealed she uses GLP-1 medication to aid weight loss after motherhood. This highlights a shift towards combining medicine with lifestyle for obesity management.

Serena Williams finally comes clean about her drastic weight change. She shares she lost 31 pounds through weight loss ...

Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to "align with federal coverage requirements." ...

Investing.com - Guggenheim heeft woensdag het koersdoel voor Eli Lilly (NYSE:LLY) verlaagd naar $ 875,00 van $ 942,00, maar ...